Cargando…
Therapeutic effects of intranasal tocotrienol-rich fraction on rhinitis symptoms in platelet-activating factor induced allergic rhinitis
BACKGROUND: Platelet-activating factor (PAF) has been suggested to be a potent inflammatory mediator in Allergic rhinitis (AR) pathogenesis. Vitamin E, an essential nutrient that comprises tocopherol and tocotrienol, is known as a potential therapeutic agent for airway allergic inflammation. This st...
Autores principales: | Teo, Cheryl Wei Ling, Png, Stephanie Jia Ying, Ung, Yee Wei, Yap, Wei Ney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195334/ https://www.ncbi.nlm.nih.gov/pubmed/35698169 http://dx.doi.org/10.1186/s13223-022-00695-x |
Ejemplares similares
-
Tocotrienol-Rich Fraction Attenuates Blue Light-Induced Oxidative Stress and Melanogenesis in B16-F1 Melanocytes via Anti-Oxidative and Anti-Tyrosinase Properties
por: Neo, Juvenia Rui En, et al.
Publicado: (2023) -
Intranasal ciclesonide for allergic rhinitis
por: Williams, Ben, et al.
Publicado: (2008) -
Intranasal administration of IL-35 inhibits allergic responses and symptoms in mice with allergic rhinitis
por: Suzuki, Motohiko, et al.
Publicado: (2017) -
Evaluating the Safety of Intranasal Steroids in the Treatment of Allergic Rhinitis
por: Sheth, Ketan
Publicado: (2008) -
Intranasal application of glucocorticoid alleviates olfactory dysfunction in mice with allergic rhinitis
por: Wang, Xiaowei, et al.
Publicado: (2017)